• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDGFA 的高表达与头颈部鳞状细胞癌的不良预后和免疫浸润有关。

Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

机构信息

Department of Otolaryngology-Head and Neck Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Department of Otolaryngology-Head and Neck Surgery, Anshun People's Hospital, Anshun, Guizhou Province, China.

出版信息

J Oral Pathol Med. 2024 Oct;53(9):584-594. doi: 10.1111/jop.13579. Epub 2024 Sep 18.

DOI:10.1111/jop.13579
PMID:39295197
Abstract

BACKGROUND

Platelet-derived growth factor A (PDGFA) has been shown to be upregulated in several tumors, contributing to their malignant phenotypes. However, its expression and function in head and neck squamous cell carcinoma (HNSC) are not clearly understood. Thus, we aimed to evaluate this issue using bioinformatic analyses and primary experimental validation.

METHODS

The expression of PDGFA was analyzed using popular bio-databases and further validated by RT-PCR and immunohistochemical staining. Survival analyses were then performed. The association between PDGFA expression levels and immune cell infiltration in the immune microenvironment was assessed.

RESULTS

PDGFA has been found to be significantly upregulated in a variety of cancers, including HNSC, and increased PDGFA expression may be an independent prognostic factor associated with immune cell infiltration in HNSC.

CONCLUSION

Overexpression of PDGFA in HNSC is significantly associated with poor prognosis and immune cell infiltration in the tumor microenvironment (TME). PDGFA has potential as a molecular indicator for diagnosis, prognosis, and immune processes in HNSC.

摘要

背景

血小板衍生生长因子 A(PDGFA)在多种肿瘤中呈上调表达,有助于其恶性表型。然而,其在头颈部鳞状细胞癌(HNSC)中的表达和功能尚不清楚。因此,我们旨在使用生物信息学分析和初步实验验证来评估这一问题。

方法

使用流行的生物数据库分析 PDGFA 的表达,并通过 RT-PCR 和免疫组织化学染色进一步验证。然后进行生存分析。评估 PDGFA 表达水平与免疫微环境中免疫细胞浸润的相关性。

结果

PDGFA 在多种癌症中呈显著上调表达,包括 HNSC,并且 PDGFA 表达增加可能是与 HNSC 中免疫细胞浸润相关的独立预后因素。

结论

HNSC 中 PDGFA 的过表达与肿瘤微环境(TME)中的不良预后和免疫细胞浸润显著相关。PDGFA 有望成为 HNSC 中诊断、预后和免疫过程的分子指标。

相似文献

1
Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.PDGFA 的高表达与头颈部鳞状细胞癌的不良预后和免疫浸润有关。
J Oral Pathol Med. 2024 Oct;53(9):584-594. doi: 10.1111/jop.13579. Epub 2024 Sep 18.
2
FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.FOXD1 在头颈部鳞癌中的表达:基于 TCGA、GEO 和荟萃分析的研究。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20210158.
3
FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.FOXD1 是一种预后生物标志物,与头颈部鳞状细胞癌中的巨噬细胞浸润相关。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20202929.
4
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma.DNA 甲基化组衍生的表观遗传指纹作为头颈部鳞状细胞癌持久临床免疫治疗获益的免疫表型标志物。
Cell Oncol (Dordr). 2024 Aug;47(4):1129-1148. doi: 10.1007/s13402-024-00917-x. Epub 2024 Feb 5.
5
Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.成纤维细胞激活蛋白(FAP)作为多种肿瘤的预后生物标志物及其在头颈部鳞状细胞癌中的治疗潜力。
Oncol Res. 2024 Jul 17;32(8):1323-1334. doi: 10.32604/or.2024.046965. eCollection 2024.
6
SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.SLC13A4 可能作为一种预后生物标志物,并与头颈部鳞状细胞癌的免疫浸润相关。
Pathol Oncol Res. 2021 Nov 10;27:1609967. doi: 10.3389/pore.2021.1609967. eCollection 2021.
7
NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.头颈部鳞状细胞癌中 NT5E 的上调:一种新型的癌症相关成纤维细胞生物标志物,可预测免疫抑制性肿瘤微环境。
Front Immunol. 2022 Aug 26;13:975847. doi: 10.3389/fimmu.2022.975847. eCollection 2022.
8
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.糖酵解上调与头颈部鳞状细胞癌的肿瘤进展和免疫逃逸相关。
Sci Rep. 2021 Sep 7;11(1):17789. doi: 10.1038/s41598-021-97292-6.
9
TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.TPPP3 与头颈部鳞状细胞癌的预后和免疫浸润有关。
Biomed Res Int. 2020 Oct 6;2020:3962146. doi: 10.1155/2020/3962146. eCollection 2020.
10
CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.CELSR3 是 HNSCC 的预后标志物,与肿瘤微环境中的免疫细胞浸润相关。
Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3143-3156. doi: 10.1007/s00405-024-08566-4. Epub 2024 Mar 20.